A randomized phase II trial of adjuvant chemotherapy with gemcitabine versus S-1 after major hepatectomy for biliary tract cancer: Kansai Hepato-Biliary Oncology Group (KHBO1208)

被引：0
|
作者：
Terajima, H. [1 ]
Kobayashi, S. [2 ]
Nagano, H. [3 ]
Tomokuni, A. [4 ]
Gotoh, K. [2 ]
Sakai, D. [5 ]
Hatano, E. [6 ]
Seo, S. [7 ]
Uchida, Y. [1 ]
Ajiki, T. [8 ]
Satake, H. [9 ]
Kamei, K. [10 ]
Tohyama, T. [11 ]
Hirose, T. [12 ]
Ikai, I. [13 ]
Morita, S. [14 ]
Ioka, T. [15 ]
机构：
[1] Kitano Hosp, Tazuke Kofu Kai Med Res Inst, Dept Gastroenterol Surg & Oncol, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan
[4] Osaka Int Canc Inst, Dept Surg, Osaka, Japan
[5] Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan
[6] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
[7] Kyoto Univ, Dept Surg, Grad Sch Med, Kyoto, Japan
[8] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Dept Surg, Kobe, Hyogo, Japan
[9] Gen Hosp, Kobe City Med Ctr, Dept Med Oncol, Kobe, Hyogo, Japan
[10] Kindai Univ, Fac Med, Dept Surg, Osakasayama, Japan
[11] Ehime Univ, Dept Hepatobiliary Pancreat & Breast Surg, Grad Sch Med, Touon, Japan
[12] Otsu Red Cross Hosp, Dept Surg, Otsu, Shiga, Japan
[13] Natl Hosp Org Kyoto Med Ctr, Dept Surg, Kyoto, Japan
[14] Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan
[15] Osaka Int Canc Inst, Dept Canc Survey & Gatrointestinal Oncol, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
762P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A MULTI-INSTITUTION PHASE II STUDY OF GEMCITABINE/CISPLATIN/S-1 (GCS) COMBINATION CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BILIARY TRACT CANCER (KHBO 1002)
    Kobayashi, S.
    Kanai, M.
    Hatano, E.
    Fujiwara, Y.
    Marubashi, S.
    Miyamoto, A.
    Shiomi, H.
    Kubo, S.
    Ikuta, S.
    Yanagimoto, H.
    Terajima, H.
    Ikoma, H.
    Sakai, D.
    Kodama, Y.
    Seo, S.
    Morita, S.
    Ajiki, T.
    Nagano, H.
    Ioka, T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S451 - S451
  • [32] Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA)
    Sakai, D.
    Kanai, M.
    Kobayashi, S.
    Eguchi, H.
    Baba, H.
    Seo, S.
    Taketomi, A.
    Takayama, T.
    Yamaue, H.
    Ishioka, C.
    Sho, M.
    Takeyama, Y.
    Fujimoto, J.
    Toyoda, M.
    Shimizu, J.
    Goto, T.
    Yoshimura, K.
    Hatano, E.
    Nagano, H.
    Ioka, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 205 - 205
  • [33] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer
    Watanabe, Akinori
    Kida, Mitsuhiro
    Miyazawa, Shiro
    Iwai, Tomohisa
    Okuwaki, Kosuke
    Kaneko, Toru
    Yamauchi, Hiroshi
    Takezawa, Miyoko
    Imaizumi, Hiroshi
    Koizumi, Wasaburo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (19) : 5979 - 5984
  • [34] A multicenter phase II of S-1 in gemcitabine-refractory biliary tract cancer
    Suzuki, E.
    Ikeda, M.
    Okusaka, T.
    Nakamori, S.
    Ohkawa, S.
    Nagakawa, T.
    Boku, N.
    Yamagimoto, H.
    Sugimori, K.
    Furuse, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Takashi Sasaki
    Hiroyuki Isayama
    Yousuke Nakai
    Yukiko Ito
    Hirofumi Kogure
    Osamu Togawa
    Nobuo Toda
    Ichiro Yasuda
    Osamu Hasebe
    Iruru Maetani
    Naoki Sasahira
    Kenji Hirano
    Takeshi Tsujino
    Minoru Tada
    Masao Omata
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1101 - 1107
  • [36] Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
    Sasaki, Takashi
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ito, Yukiko
    Kogure, Hirofumi
    Togawa, Osamu
    Toda, Nobuo
    Yasuda, Ichiro
    Hasebe, Osamu
    Maetani, Iruru
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (06) : 1101 - 1107
  • [37] Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer
    Hosoda, Kiyotaka
    Fukushima, Kentaro
    Shimizu, Akira
    Motoyama, Hiroaki
    Kubota, Koji
    Notake, Tsuyoshi
    Sugenoya, Shinsuke
    Hayashi, Hikaru
    Yasukawa, Koya
    Kobayashi, Ryoichiro
    Soejima, Yuji
    ONCOLOGY, 2021, 99 (11) : 703 - 712
  • [38] Randomized clinical trial of adjuvant chemotherapy with S-1 versus gemcitabine after pancreatic cancer resection
    Shimoda, M.
    Kubota, K.
    Shimizu, T.
    Katoh, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 (07) : 746 - 754
  • [39] A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
    Suzuki, Eiichiro
    Ikeda, Masafumi
    Okusaka, Takuji
    Nakamori, Shoji
    Ohkawa, Shinichi
    Nagakawa, Tatsuya
    Boku, Narikazu
    Yanagimoto, Hiroaki
    Sato, Tosiya
    Furuse, Junji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1141 - 1146
  • [40] A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer
    Eiichiro Suzuki
    Masafumi Ikeda
    Takuji Okusaka
    Shoji Nakamori
    Shinichi Ohkawa
    Tatsuya Nagakawa
    Narikazu Boku
    Hiroaki Yanagimoto
    Tosiya Sato
    Junji Furuse
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1141 - 1146
12345